                    >
                
                        About Us
                    
                    >
                
                        Company Overview
                    
                    >
                
                        Management Team
                    
                    >
                
                        Board Of Directors
                    
                    >
                
                        Advisory Board
                    
                    >
                
                        Investors
                    
                    >
                
                        Contact Us

News

Teva will invest up to additional $10.5 Million in CureTech.

CureTech announces receipt of a Notice of Allowance from the US Patent and Trademark Office

Teva Pharmaceuticals To Invest $6 Million In CureTech

> Investors

CureTech Investors include Clal Biotechnology Industries, Clal Venture Capital, Teva Pharmaceuticals Ltd., Koonras Technologies and Technorov Holdings.